Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 2 (2005), Issue 1 (January)

1. The novel targets for anti-angiogenesis of genistein on human cancer cells.
   Biochem Pharmacol, 69(2): 307-18. [Abstract] [Full-text]
2. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
   Int J Pediatr Otorhinolaryngol, 69(1): 75-80. [Abstract] [Full-text]
3. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
   Semin Thromb Hemost, 30(6): 609-18. [Abstract] [Full-text]
4. Prophylactic antibiotic use in pediatric burn units.
   Eur J Pediatr Surg, 14(6): 422-6. [Abstract] [Full-text]
5. The treatment of rectal prolapse in children with phenol in almond oil injection.
   Eur J Pediatr Surg, 14(6): 414-7. [Abstract] [Full-text]
6. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system.
   Thromb Haemost, 93(1): 106-14. [Abstract] [Full-text]
7. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
   Thromb Haemost, 93(1): 35-9. [Abstract] [Full-text]
8. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
   J Clin Invest, 115(1): 128-37. [Abstract] [Full-text]
9. Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
   Int J Radiat Oncol Biol Phys, 61(1): 175-84. [Abstract] [Full-text]
10. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Int J Radiat Oncol Biol Phys, 61(1): 70-5. [Abstract] [Full-text]
11. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    J Am Coll Cardiol, 45(1): 25-9. [Abstract] [Full-text]
12. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment.
    Am J Ophthalmol, 138(6): 1077-9. [Abstract] [Full-text]
13. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin.
    J Photochem Photobiol B, 78(1): 1-6. [Abstract] [Full-text]
14. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.
    Trends Pharmacol Sci, 26(1): 27-35. [Abstract] [Full-text]
15. Versatile peptide dendrimers for nucleic acid delivery.
    J Pharm Sci, 94(2): 446-57. [Abstract] [Full-text]
16. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
    J Infect Dis, 191(3): 348-57. [Abstract] [Full-text]
17. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.
    J Infect Dis, 191(3): 339-47. [Abstract] [Full-text]
18. Dehydroepiandrosterone replacement therapy.
    Semin Reprod Med, 22(4): 379-88. [Abstract] [Full-text]
19. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute.
    J Bone Joint Surg Am, 87(1): 107-12. [Abstract] [Full-text]
20. Neurotoxicity of cancer chemotherapy.
    Semin Neurol, 24(4): 419-26. [Abstract] [Full-text]
21. Reporting of medication errors by pediatric nurses.
    J Pediatr Nurs, 19(6): 385-92. [Abstract] [Full-text]
22. Oral cancer prevention and the evolution of molecular-targeted drug development.
    J Clin Oncol, 23(2): 346-56. [Abstract] [Full-text]
23. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
    J Clin Oncol, 23(2): 254-66. [Abstract] [Full-text]
24. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    Pediatr Crit Care Med, 6(1): 25-32. [Abstract] [Full-text]
25. FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.
    Jpn J Clin Oncol, 34(12): 747-50. [Abstract] [Full-text]
26. Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.
    Lung Cancer, 47(2): 277-81. [Abstract] [Full-text]
27. Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
    Lung Cancer, 47(2): 269-75. [Abstract] [Full-text]
28. Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.
    Lung Cancer, 47(2): 261-7. [Abstract] [Full-text]
29. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
    Lung Cancer, 47(2): 253-9. [Abstract] [Full-text]
30. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
    Surg Neurol, 63(1): 52-5; discussion 55. [Abstract] [Full-text]
31. Synthesis and NMR characterization of hydroxyurea and mesylglycol glycoconjugates as drug candidates for targeted cancer chemotherapy.
    Carbohydr Res, 340(2): 181-9. [Abstract] [Full-text]
32. Thrombolytic therapy: current clinical practice.
    Hematol Oncol Clin North Am, 19(1): 147-81, vii. [Abstract] [Full-text]
33. Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies.
    Br J Haematol, 128(2): 184-91. [Abstract] [Full-text]
34. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
    Br J Haematol, 128(2): 177-83. [Abstract] [Full-text]
35. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
    Biomacromolecules, 6(1): 341-50. [Abstract] [Full-text]
36. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
    Biomacromolecules, 6(1): 271-8. [Abstract] [Full-text]
37. Novel biodegradable polymers as gene carriers.
    Macromol Biosci, 4(12): 1113-7. [Abstract] [Full-text]
38. Coccidioidomycosis in patients with hematologic malignancies.
    Arch Intern Med, 165(1): 113-7. [Abstract] [Full-text]
39. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents.
    Arch Intern Med, 165(1): 68-74. [Abstract] [Full-text]
40. Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice.
    Arch Ophthalmol, 123(1): 58-63. [Abstract] [Full-text]
41. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.
    Am J Cardiol, 95(2): 289-91. [Abstract] [Full-text]
42. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction.
    Am J Cardiol, 95(2): 228-33. [Abstract] [Full-text]
43. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
    Am J Cardiol, 95(2): 224-7. [Abstract] [Full-text]
44. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.
    Eur J Surg Oncol, 31(1): 67-73. [Abstract] [Full-text]
45. Neoadjuvant chemotherapy in breast cancer.
    Br J Surg, 92(1): 14-23. [Abstract] [Full-text]
46. Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage.
    J Neurol, 251(12): 1443-50. [Abstract] [Full-text]
47. Mortality in overweight and underweight children with acute myeloid leukemia.
    JAMA, 293(2): 203-11. [Abstract] [Full-text]
48. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs.
    Artif Organs, 29(1): 83-7. [Abstract] [Full-text]
49. Computerized physician order entry from a chief information officer perspective.
    J Crit Care, 19(4): 283-9. [Abstract] [Full-text]
50. Translation and interpretation: the hidden processes and problems revealed by computerized physician order entry systems.
    J Crit Care, 19(4): 279-82. [Abstract] [Full-text]
51. Computerized physician order entry in the critical care and general inpatient setting: a narrative review.
    J Crit Care, 19(4): 271-8. [Abstract] [Full-text]
52. Opioid use by patients in an orthopedics spine clinic.
    Arthritis Rheum, 52(1): 312-21. [Abstract] [Full-text]
53. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    J Womens Health (Larchmt), 13(10): 1080-6. [Abstract] [Full-text]
54. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
    Clin Microbiol Infect, 11(1): 57-62. [Abstract] [Full-text]
55. Effect of reperfusion on P-wave duration and P-wave dispersion in acute myocardial infarction: primary angioplasty versus thrombolytic therapy.
    Ann Noninvasive Electrocardiol, 10(1): 35-40. [Abstract] [Full-text]
56. Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials.
    Inflamm Res, 53(12): 697-705. [Abstract] [Full-text]
57. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review.
    Bull World Health Organ, 82(12): 935-9. [Abstract] [Full-text]
58. Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion.
    J Neurol Neurosurg Psychiatry, 76(2): 196-9. [Abstract] [Full-text]
59. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
    J Clin Virol, 32(2): 151-5. [Abstract] [Full-text]
60. Compliance with hormone replacement therapy in postmenopausal Sicilian women.
    Eur J Obstet Gynecol Reprod Biol, 118(2): 225-8. [Abstract] [Full-text]
61. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
    J Control Release, 102(2): 489-507. [Abstract] [Full-text]
62. Cell targeting by a generic receptor-targeted polymer nanocontainer platform.
    J Control Release, 102(2): 475-88. [Abstract] [Full-text]
63. Controlling release from the lipidic cubic phase by selective alkylation.
    J Control Release, 102(2): 441-61. [Abstract] [Full-text]
64. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
    J Control Release, 102(2): 333-44. [Abstract] [Full-text]
65. Non-viral gene delivery for local and controlled DNA release.
    J Control Release, 102(1): 263-75. [Abstract] [Full-text]
66. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
    J Control Release, 102(1): 247-53. [Abstract] [Full-text]
67. Incorporation of low molecular weight biocides into polystyrene-divinyl benzene beads with controlled release characteristics.
    J Control Release, 102(1): 223-33. [Abstract] [Full-text]
68. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.
    J Control Release, 102(1): 203-22. [Abstract] [Full-text]
69. Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
    J Control Release, 102(1): 191-201. [Abstract] [Full-text]
70. Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients.
    J Control Release, 102(1): 181-90. [Abstract] [Full-text]
71. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.
    J Control Release, 102(1): 159-69. [Abstract] [Full-text]
72. A model for drug release from fast phase inverting injectable solutions.
    J Control Release, 102(1): 145-57. [Abstract] [Full-text]
73. Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics.
    J Control Release, 102(1): 123-33. [Abstract] [Full-text]
74. Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.
    J Control Release, 102(1): 113-22. [Abstract] [Full-text]
75. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    J Control Release, 102(1): 85-99. [Abstract] [Full-text]
76. Application of Eudragit RS to thermo-sensitive drug delivery systems: II. Effect of temperature on drug permeability through membrane consisting of Eudragit RS/PEG 400 blend polymers.
    J Control Release, 102(1): 49-57. [Abstract] [Full-text]
77. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
    J Control Release, 102(1): 23-38. [Abstract] [Full-text]
78. Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro.
    J Control Release, 102(1): 13-22. [Abstract] [Full-text]
79. Influence of different HRT regimens on mammographic density.
    Maturitas, 50(2): 105-10. [Abstract] [Full-text]
80. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Maturitas, 50(2): 91-7. [Abstract] [Full-text]
81. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Maturitas, 50(2): 78-85. [Abstract] [Full-text]
82. Photodynamic therapy induced esophageal stricture--an animal model: from mouse to pig.
    J Surg Res, 123(1): 67-74. [Abstract] [Full-text]
83. Functional changes after photodynamic therapy with verteporfin.
    Am J Ophthalmol, 139(1): 214-5. [Abstract] [Full-text]
84. Moral hazard and prescription medicine use in Australia--the patient perspective.
    Soc Sci Med, 60(7): 1437-43. [Abstract] [Full-text]
85. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat.
    J Neurosci Methods, 142(1): 115-24. [Abstract] [Full-text]
86. Applying small quantities of multiple compounds to defined locations of in vitro brain slices.
    J Neurosci Methods, 142(1): 55-66. [Abstract] [Full-text]
87. A stimulation method using odors suitable for PET and fMRI studies with recording of physiological and behavioral signals.
    J Neurosci Methods, 142(1): 35-44. [Abstract] [Full-text]
88. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
    Farmaco, 60(1): 27-31. [Abstract] [Full-text]
89. A novel method to calculate the extent and amount of drug transported into CSF after intranasal administration.
    Int J Pharm, 289(1): 159-66. [Abstract] [Full-text]
90. A new scleroglucan/borax hydrogel: swelling and drug release studies.
    Int J Pharm, 289(1): 97-107. [Abstract] [Full-text]
91. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
    Int J Pharm, 289(1): 63-7. [Abstract] [Full-text]
92. Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier.
    Int J Pharm, 289(1): 51-62. [Abstract] [Full-text]
93. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Cancer, 103(2): 368-76. [Abstract] [Full-text]
94. Application of adjuvant chemotherapy in colorectal cancer -- a survey in the region of Essen, Germany.
    Onkologie, 28(1): 7-10. [Abstract] [Full-text]
95. Malignant melanoma and HIV infection -- aggressive course despite immune reconstitution.
    Onkologie, 28(1): 35-7. [Abstract] [Full-text]
96. Chemotherapy in metastatic colorectal cancer.
    Tech Coloproctol, 8: s43-6. [Abstract] [Full-text]
97. Current treatment of colorectal liver metastases.
    Tech Coloproctol, 8: s174-6. [Abstract] [Full-text]
98. Risk factors for estrogen receptor-positive breast cancer.
    Arch Surg, 140(1): 58-62. [Abstract] [Full-text]
99. Cost comparison of surgery vs organ preservation for laryngeal cancer.
    Arch Otolaryngol Head Neck Surg, 131(1): 21-6. [Abstract] [Full-text]
100. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.
     Arch Dermatol, 141(1): 60-7. [Abstract] [Full-text]
101. Development and implementation of a medication adherence training instrument for persons living with HIV: the MATI.
     Behav Modif, 29(2): 286-317. [Abstract] [Full-text]
102. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
     J Natl Cancer Inst, 97(2): 116-26. [Abstract] [Full-text]
103. Effect of estrogen therapy on gallbladder disease.
     JAMA, 293(3): 330-9. [Abstract] [Full-text]
104. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
     Bioconjug Chem, 16(1): 230-6. [Abstract] [Full-text]
105. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
     Bioconjug Chem, 16(1): 122-30. [Abstract] [Full-text]
106. Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines.
     Bioconjug Chem, 16(1): 80-9. [Abstract] [Full-text]
107. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
     Bioconjug Chem, 16(1): 32-42. [Abstract] [Full-text]
108. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
     Cancer Gene Ther, 12(2): 133-40. [Abstract] [Full-text]
109. Photodynamic therapy and indocyanine green guided feeder vessel photocoagulation of choroidal neovascularization secondary to choroid rupture after blunt trauma.
     Graefes Arch Clin Exp Ophthalmol, 243(1): 68-71. [Abstract] [Full-text]
110. ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction.
     Am Heart J, 149(1): 91-7. [Abstract] [Full-text]
111. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).
     Am Heart J, 149(1): 67-73. [Abstract] [Full-text]
112. Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort.
     AIDS Patient Care STDS, 18(12): 721-7. [Abstract] [Full-text]
113. Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).
     AIDS Patient Care STDS, 18(12): 702-13. [Abstract] [Full-text]
114. Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.
     J Clin Oncol, 23(3): 569-75. [Abstract] [Full-text]
115. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
     J Clin Oncol, 23(3): 541-7. [Abstract] [Full-text]
116. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
     J Clin Oncol, 23(3): 532-40. [Abstract] [Full-text]
117. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
     J Clin Oncol, 23(3): 525-31. [Abstract] [Full-text]
118. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
     J Clin Oncol, 23(3): 502-9. [Abstract] [Full-text]
119. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
     J Clin Oncol, 23(3): 494-501. [Abstract] [Full-text]
120. Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
     J Clin Oncol, 23(3): 432-40. [Abstract] [Full-text]
121. Conditions affecting hydrodynamics-based gene delivery into mouse liver in vivo.
     Clin Exp Pharmacol Physiol, 31(12): 850-5. [Abstract] [Full-text]
122. Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease.
     J Clin Pharm Ther, 30(1): 77-84. [Abstract] [Full-text]
123. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.
     J Clin Pharm Ther, 30(1): 65-71. [Abstract] [Full-text]
124. Methylphenidate: prescribing patterns in a South African primary care patient population.
     J Clin Pharm Ther, 30(1): 59-63. [Abstract] [Full-text]
125. Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004).
     Eur J Clin Pharmacol, 60(11): 831-4. [Abstract] [Full-text]
126. Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients.
     J Clin Oncol, 23(3): 413-21. [Abstract] [Full-text]
127. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers.
     J Biomed Mater Res B Appl Biomater, 72(2): 373-8. [Abstract] [Full-text]
128. Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.
     Eur J Clin Pharmacol, 60(11): 797-805. [Abstract] [Full-text]
129. Pilot study of a paediatric emergency department oral rehydration protocol.
     Emerg Med J, 22(2): 116-7. [Abstract] [Full-text]
130. Understanding physicians' attitudes towards hormone therapy.
     Womens Health Issues, 15(1): 31-8. [Abstract] [Full-text]
131. A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
     Crit Rev Oncol Hematol, 53(2): 133-9. [Abstract] [Full-text]
132. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
     Crit Rev Oncol Hematol, 53(2): 125-31. [Abstract] [Full-text]
133. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
     Eur J Cancer, 41(2): 249-55. [Abstract] [Full-text]
134. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
     Eur J Cancer, 41(2): 225-30. [Abstract] [Full-text]
135. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release.
     Eur J Pharm Biopharm, 59(2): 367-71. [Abstract] [Full-text]
136. Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells.
     Eur J Pharm Biopharm, 59(2): 359-66. [Abstract] [Full-text]
137. Studies on a new device for drug delivery to the eye.
     Eur J Pharm Biopharm, 59(2): 283-8. [Abstract] [Full-text]
138. A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia.
     Leuk Res, 29(3): 263-71. [Abstract] [Full-text]
139. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
     Gynecol Oncol, 96(2): 490-5. [Abstract] [Full-text]
140. A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8).
     Gynecol Oncol, 96(2): 444-51. [Abstract] [Full-text]
141. A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.
     Gynecol Oncol, 96(2): 374-80. [Abstract] [Full-text]
142. Evaluation of weekly low-dose paclitaxel and carboplatin treatment for patients with platinum-sensitive relapsed ovarian cancer.
     Gynecol Oncol, 96(2): 323-9. [Abstract] [Full-text]
143. A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma.
     Gynecol Oncol, 96(2): 296-300. [Abstract] [Full-text]
144. Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
     J Cancer Res Clin Oncol, 131(3): 152-6. [Abstract] [Full-text]
145. Locally advanced breast cancer in octogenarian women.
     Breast Cancer Res Treat, 89(1): 81-90. [Abstract] [Full-text]
146. Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.
     Breast Cancer Res Treat, 89(1): 1-3. [Abstract] [Full-text]
147. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
     J Womens Health (Larchmt), 13(9): 993-9. [Abstract] [Full-text]
148. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
     J Womens Health (Larchmt), 13(9): 986-92. [Abstract] [Full-text]
149. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
     J Womens Health (Larchmt), 13(9): 975-85. [Abstract] [Full-text]
150. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
     AIDS Patient Care STDS, 19(1): 31-9. [Abstract] [Full-text]
151. Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: patient satisfaction and implications for adherence.
     AIDS Patient Care STDS, 19(1): 9-18. [Abstract] [Full-text]
152. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.
     Br J Ophthalmol, 89(2): 147-50. [Abstract] [Full-text]
153. CVP and PAoP measurements are discordant during fluid therapy after traumatic brain injury.
     J Intensive Care Med, 20(1): 28-33. [Abstract] [Full-text]
154. Off licence and off label prescribing in children: litigation fears for physicians.
     Arch Dis Child, 90: i17-8. [Abstract] [Full-text]
155. Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells.
     Bioorg Med Chem Lett, 15(3): 621-4. [Abstract] [Full-text]
156. Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa.
     Psychiatry Res, 132(3): 197-207. [Abstract] [Full-text]
157. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
     J Photochem Photobiol B, 78(2): 135-40. [Abstract] [Full-text]
158. Pulsed estradiol exposure has a limited ability to induce uterine proliferation in ovariectomised female Wistar rats.
     Mol Cell Endocrinol, 230(1): 7-15. [Abstract] [Full-text]
159. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
     Int J Pharm, 290(1): 155-9. [Abstract] [Full-text]
160. Preparation of prostaglandin E1-hydroxypropyl-beta-cyclodextrin complex and its nasal delivery in rats.
     Int J Pharm, 290(1): 101-8. [Abstract] [Full-text]
161. Chitosan-alginate multilayer beads for controlled release of ampicillin.
     Int J Pharm, 290(1): 45-54. [Abstract] [Full-text]
162. Comparison of morphine and butorphanol as pre-anaesthetic agents in combination with romifidine for field castration in ponies.
     Vet Anaesth Analg, 32(1): 16-22. [Abstract] [Full-text]
163. Self-medication of mental health problems: new evidence from a national survey.
     Health Serv Res, 40(1): 117-34. [Abstract] [Full-text]
164. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
     BJOG, 112(2): 228-33. [Abstract] [Full-text]
165. Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.
     Neuroendocrinology, 80(4): 244-51. [Abstract] [Full-text]
166. Coronary artery spasm induced by 5-fluorouracil.
     Z Kardiol, 94(1): 33-7. [Abstract] [Full-text]
167. Access-site complications after rescue percutaneous coronary intervention during thrombolysis for acute myocardial infarction.
     Z Kardiol, 94(1): 23-7. [Abstract] [Full-text]
168. Combined IV and intra-arterial thrombolysis for acute ischemic stroke.
     Neurology, 64(2): 386-8. [Abstract] [Full-text]
169. Patient-reported medication symptoms in primary care.
     Arch Intern Med, 165(2): 234-40. [Abstract] [Full-text]
170. Errors in the medication process: frequency, type, and potential clinical consequences.
     Int J Qual Health Care, 17(1): 15-22. [Abstract] [Full-text]
171. The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
     Ann Oncol, 16(2): 307-13. [Abstract] [Full-text]
172. Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.
     Ann Oncol, 16(2): 300-6. [Abstract] [Full-text]
173. Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial.
     Ann Oncol, 16(2): 294-9. [Abstract] [Full-text]
174. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.
     Ann Oncol, 16(2): 279-81. [Abstract] [Full-text]
175. Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.
     Ann Oncol, 16(2): 267-72. [Abstract] [Full-text]
176. Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer.
     Ann Oncol, 16(2): 247-52. [Abstract] [Full-text]
177. Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.
     Ann Oncol, 16(2): 234-9. [Abstract] [Full-text]
178. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials.
     Ann Oncol, 16(2): 228-33. [Abstract] [Full-text]
179. Long-term survival after surgical intervention for bone disease in multiple myeloma.
     Ann Oncol, 16(2): 222-7. [Abstract] [Full-text]
180. Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma.
     Ann Oncol, 16(2): 219-21. [Abstract] [Full-text]
181. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia.
     Ann Oncol, 16(2): 195-205. [Abstract] [Full-text]
182. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
     Int J Radiat Oncol Biol Phys, 61(2): 380-6. [Abstract] [Full-text]
183. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
     Urology, 65(1): 126-30. [Abstract] [Full-text]
184. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
     Br J Haematol, 128(3): 343-50. [Abstract] [Full-text]
185. Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience.
     Intern Med J, 35(1): 34-8. [Abstract] [Full-text]
186. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
     J Am Soc Nephrol, 16(2): 452-8. [Abstract] [Full-text]
187. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model.
     Radiology, 234(2): 431-7. [Abstract] [Full-text]
188. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.
     Am J Cardiol, 95(3): 383-6. [Abstract] [Full-text]
189. Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction.
     Am J Cardiol, 95(3): 379-82. [Abstract] [Full-text]
190. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia.
     Public Health Nurs, 22(1): 36-44. [Abstract] [Full-text]
191. A case of protrusion of an intraperitoneal chemotherapy catheter through rectum.
     Int J Gynecol Cancer, 15(1): 171-4. [Abstract] [Full-text]
192. Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy.
     Int J Gynecol Cancer, 15(1): 45-9. [Abstract] [Full-text]
193. An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control.
     Artif Organs, 29(2): 131-43. [Abstract] [Full-text]
194. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
     HIV Med, 6(1): 51-3. [Abstract] [Full-text]
195. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
     HIV Med, 6(1): 37-44. [Abstract] [Full-text]
196. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
     HIV Med, 6(1): 7-12. [Abstract] [Full-text]
197. Changes in thyroid hormone state in children receiving chemotherapy.
     Clin Endocrinol (Oxf), 62(2): 250-7. [Abstract] [Full-text]
198. Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary?
     J Thromb Haemost, 3(2): 216-20. [Abstract] [Full-text]
199. Over-the-counter medicine use prior to and during hospitalization.
     Ann Pharmacother, 39(2): 268-73. [Abstract] [Full-text]
200. Thrombolytic agents for arterial and venous thromboses in neonates.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
201. Urinary catheter policies for long-term bladder drainage.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
202. Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion.
     Surgery, 137(2): 156-64. [Abstract] [Full-text]
203. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations.
     J Am Geriatr Soc, 53(2): 262-7. [Abstract] [Full-text]
204. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.
     J Am Geriatr Soc, 53(2): 227-32. [Abstract] [Full-text]
205. HAART-related nephropathies in HIV-infected patients.
     Kidney Int, 67(2): 393-403. [Abstract] [Full-text]
206. High-throughput target discovery using cell-based genetics.
     Drug Discov Today, 10(1): 53-60. [Abstract] [Full-text]
207. Dendrimers and dendritic polymers in drug delivery.
     Drug Discov Today, 10(1): 35-43. [Abstract] [Full-text]
208. Perspectives of cellular and molecular neurosurgery.
     J Neurooncol, 70(2): 255-69. [Abstract] [Full-text]
209. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
     BMJ, 330(7485): 217. [Abstract] [Full-text]
210. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
     BMC Cancer, 5(1): 2. [Abstract] [Full-text]
211. A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study).
     J Antimicrob Chemother, 55(2): 246-51. [Abstract] [Full-text]
212. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
     J Antimicrob Chemother, 55(2): 269-71. [Abstract] [Full-text]
213. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
     Biol Blood Marrow Transplant, 11(2): 93-100. [Abstract] [Full-text]
214. Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence.
     Sex Transm Infect, 81(1): 5-14. [Abstract] [Full-text]
215. Concurrent proton beam radiotherapy and systemic chemotherapy for the metastatic liver tumor of gastric carcinoma: a case report.
     Jpn J Clin Oncol, 35(1): 40-4. [Abstract] [Full-text]
216. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
     Jpn J Clin Oncol, 35(1): 13-7. [Abstract] [Full-text]
217. Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.
     Jpn J Clin Oncol, 35(1): 6-12. [Abstract] [Full-text]
218. Influence of sex on toxicity and treatment outcome in small-cell lung cancer.
     J Clin Oncol, 23(4): 850-6. [Abstract] [Full-text]
219. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
     J Clin Oncol, 23(4): 792-9. [Abstract] [Full-text]
220. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
     J Clin Oncol, 23(4): 694-704. [Abstract] [Full-text]
221. Specific targeting of ultrasound contrast agent (USCA) for diagnostic application: an in vitro feasibility study based on SAW biosensor.
     Biosens Bioelectron, 20(9): 1829-35. [Abstract] [Full-text]
222. Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal disease.
     Clin Nutr, 24(1): 158-63. [Abstract] [Full-text]
223. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
     J Control Release, 102(3): 669-77. [Abstract] [Full-text]
224. Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.
     J Control Release, 102(3): 657-68. [Abstract] [Full-text]
225. A new polysaccharidic gel matrix for drug delivery: preparation and mechanical properties.
     J Control Release, 102(3): 643-56. [Abstract] [Full-text]
226. Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer.
     J Control Release, 102(3): 607-17. [Abstract] [Full-text]
227. Cationic charge-dependent hepatic delivery of amidated serum albumin.
     J Control Release, 102(3): 583-94. [Abstract] [Full-text]
228. Amorphous oxide--a platform for drug delivery.
     J Control Release, 102(3): 539-49. [Abstract] [Full-text]
229. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
     J Control Release, 102(3): 525-38. [Abstract] [Full-text]
230. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
     Ann Thorac Surg, 79(2): 391-7; discussionn 391-7. [Abstract] [Full-text]
231. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine.
     J Am Coll Cardiol, 45(3): 329-35. [Abstract] [Full-text]
232. Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis.
     Surg Neurol, 63(2): 107-12; discussion 112-3. [Abstract] [Full-text]
233. Prehospital thrombolysis perfomed by a ship's nurse with on-line physician consultation.
     Resuscitation, 64(2): 233-6. [Abstract] [Full-text]
234. In vivo evaluation of a colonic delivery system using isotope techniques.
     Aliment Pharmacol Ther, 21(2): 187-94. [Abstract] [Full-text]
235. Hospital doctors and their schemas about appropriate prescribing.
     Med Educ, 39(2): 184-93. [Abstract] [Full-text]
236. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak.
     BMC Public Health, 5(1): 2. [Abstract] [Full-text]
237. Community-based outpatient practice of antibiotics use in Tehran.
     Pharmacoepidemiol Drug Saf, 14(2): 135-8. [Abstract] [Full-text]
238. Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.
     Arterioscler Thromb Vasc Biol, 25(2): 399-405. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.